From the American Academy of Ophthalmology

The retrospective review included 110 patients with AMD, 75 phakic eyes and 45 pseudophakic. Subjects received three monthly loading dose injections of ranibizumab, followed by prn treatment. At 18 months follow-up, the average number of injections was 3.87 in the phakic group and 3.62 in the pseudophakic group. There was no difference between the groups in terms of improved BCVA or central macular thickness. Retina, March 2013